14.04 (-%)
As of Nov 20, 2024
Source:
Inhibrx, Inc. is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using our proprietary modular protein engineering platforms.
Country | United States |
Headquarters | la jolla, california |
Phone Number | (858) 795-4220 |
Industry | manufacturing |
CEO | Mark P. Lappe |
Website | www.inhibrx.com |